DELIVRA HEALTH BRANDS INC (DHB.CA) Forecast, Price Target & Analyst Ratings

TSX-V:DHBCA24703H2019

Current stock price

0.17 CAD
+0.01 (+3.03%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for DELIVRA HEALTH BRANDS INC (DHB.CA).

Forecast Snapshot

Consensus Price Target

Price Target
CA$0.73
+ 332.00% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 19, 2026

ChartMill Buy Consensus

Rating
84.44%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
CA$0.73
Upside
+ 332.00%
From current price of CA$0.17 to mean target of CA$0.73, Based on 9 analyst forecasts
Low
CA$0.73
Median
CA$0.73
High
CA$0.76

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

9 Wall Street analysts provided a forecast for the next 12 months for DHB.CA. The average price target is 0.73 CAD. This implies a price increase of 332% is expected in the next year compared to the current price of 0.17.

Analyst Ratings & History

Current Analyst Ratings

DHB Current Analyst RatingDHB Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

DHB Historical Analyst RatingsDHB Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
84.44%
DHB.CA was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about DHB.CA.
In the previous month the buy percentage consensus was at a similar level.
DHB.CA was analyzed by 9 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 19, 2026

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027
Revenue
YoY % growth
DHB.CA revenue by date.DHB.CA revenue by date.
9.791M
20.28%
12.378M
26.42%
13.37M
8.01%
15.25M
14.06%
17.321M
13.58%
EBITDA
YoY % growth
DHB.CA ebitda by date.DHB.CA ebitda by date.
365K
111.70%
845K
131.51%
363K
-57.04%
1.22M
236.09%
1.905M
56.15%
EBIT
YoY % growth
DHB.CA ebit by date.DHB.CA ebit by date.
-965K
81.58%
-464K
51.92%
-905K
-95.04%
-156.56K
82.70%
542.369K
446.43%
Operating Margin
DHB.CA operating margin by date.DHB.CA operating margin by date.
-9.86%-3.75%-6.77%-1.03%3.13%
EPS
YoY % growth
DHB.CA eps by date.DHB.CA eps by date.
N/AN/AN/A-0.01
80.00%
0.01
210.00%

All data in CAD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in CAD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

DHB.CA Yearly Revenue VS EstimatesDHB.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M
DHB.CA Yearly EPS VS EstimatesDHB.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2025 2026 2027 0 -0.2 -0.4 -0.6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

DELIVRA HEALTH BRANDS INC / DHB.CA Forecast FAQ

What do analysts expect the price target to be for DELIVRA HEALTH BRANDS INC (DHB.CA)?

9 analysts have analysed DHB.CA and the average price target is 0.73 CAD. This implies a price increase of 332% is expected in the next year compared to the current price of 0.17.

What is the next earnings date for DHB stock?

DELIVRA HEALTH BRANDS INC (DHB.CA) will report earnings on 2026-05-19.